Left and right ventricular longitudinal systolic function following aortic valve replacement in the PARTNER 2 trial and registry

Abstract Aims Evaluation of left and right ventricular (RV) longitudinal systolic function may enhance risk stratification following aortic valve replacement (AVR). The study objective was to evaluate the changes in left and RV longitudinal systolic function and RV–pulmonary artery (RV–PA) coupling...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European heart journal cardiovascular imaging 2024-08, Vol.25 (9), p.1276-1286
Hauptverfasser: Silva, Iria, Ternacle, Julien, Hahn, Rebecca T, Salah-Annabi, Mohamed, Dahou, Abdellaziz, Krapf, Laura, Salaun, Erwan, Guzzetti, Ezequiel, Xu, Ke, Clavel, Marie-Annick, Bernier, Mathieu, Beaudoin, Jonathan, Cremer, Paul C, Jaber, Wael, Rodriguez, Leonardo, Asch, Federico M, Weismann, Neil J, Bax, Jeroen, Ajmone, Nina, Alu, Maria C, Kallel, Faouzi, Mack, Michael J, Webb, John G, Kapadia, Samir, Makkar, Raj, Kodali, Susheel, Herrmann, Howard C, Thourani, Vinod, Leon, Martin B, Pibarot, Philippe
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Abstract Aims Evaluation of left and right ventricular (RV) longitudinal systolic function may enhance risk stratification following aortic valve replacement (AVR). The study objective was to evaluate the changes in left and RV longitudinal systolic function and RV–pulmonary artery (RV–PA) coupling from baseline to 30 days and 1 year after AVR. Methods and results Left ventricular (LV) longitudinal strain (LS), tricuspid annulus plane systolic excursion (TAPSE), and RV–PA coupling were evaluated in patients from the PARTNER 2A surgical AVR (SAVR) arm (n = 985) and from the PARTNER 2 SAPIEN 3 registry (n = 719). TAPSE and RV–PA coupling decreased significantly following SAVR, but remained stable following TAVR. Lower LV LS, TAPSE, or RV–PA coupling at baseline was associated with increased risk of the composite of death, hospitalization, and stroke at 5 years [adjusted hazard ratios (HRs) for LV LS < 15%: 1.24, 95% confidence interval (CI) 1.05–1.45, P = 0.001; TAPSE < 14 mm: 1.44, 95% CI 1.21–1.73, P < 0.001; RV–PA coupling < 0.55 mm/mmHg: 1.32, 95% CI 1.07–1.63, P = 0.011]. Reduced TAPSE at baseline was the most powerful predictor of the composite endpoint at 5 years. Patients with LV ejection fraction
ISSN:2047-2404
2047-2412
2047-2412
DOI:10.1093/ehjci/jeae114